AGN 2.99% 86.0¢ argenica therapeutics limited

Ann: ARG-007 Protects Brain Cells in Moderate TBI Model, page-3

  1. 52 Posts.
    lightbulb Created with Sketch. 16
    In the report, when you read "equivalent to non-injured animals" and "also significantly reducedback to non-injured levels", there is a sense of optimism and hope that this could develop into a significant biotech company. Currently well funded and hopefully will attract support in the future, Early days, but exciting future.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
(20min delay)
Last
86.0¢
Change
0.025(2.99%)
Mkt cap ! $106.3M
Open High Low Value Volume
86.0¢ 86.0¢ 82.5¢ $113.0K 133.6K

Buyers (Bids)

No. Vol. Price($)
1 400 82.5¢
 

Sellers (Offers)

Price($) Vol. No.
86.0¢ 619 1
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.